GN Store Nord A/S (CPH:GN)
99.84
+1.02 (1.03%)
Aug 10, 2026, 4:59 PM CET
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 14.39 billion as of August 10, 2026. Its market cap has increased by 1.54% in one year.
Market Cap
14.39B
Enterprise Value
23.48B
Revenue
16.60B
Ranking
n/a
PE Ratio
54.92
Stock Price
99.84
ChartMarket Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 14.39B, an increase of 4,258.52%. That is a compound annual growth rate of 11.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 14.39B | -7.43% |
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Genmab | 119.34B |
| Coloplast | 98.51B |
| Demant | 59.52B |
| H. Lundbeck | 40.02B |
| Zealand Pharma | 23.25B |
| Ambu A/S | 19.37B |
| Bavarian Nordic | 13.47B |